These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34346865)

  • 1. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 2. Could new COVID variants undermine vaccines? Labs scramble to find out.
    Callaway E
    Nature; 2021 Jan; 589(7841):177-178. PubMed ID: 33432212
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
    Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
    Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omicron likely to weaken COVID vaccine protection.
    Callaway E
    Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
    [No Abstract]   [Full Text] [Related]  

  • 7. How 'killer' T cells could boost COVID immunity in face of new variants.
    Ledford H
    Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
    [No Abstract]   [Full Text] [Related]  

  • 8. Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice.
    Wang W; Huang B; Zhu Y; Tan W; Zhu M
    Cell Mol Immunol; 2021 Mar; 18(3):749-751. PubMed ID: 33580169
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral Proteins under 70 Kilodaltons in Size Prevent the Development of Long-Lasting B-Cell Immune Memory and IgG2a Prevention in COVID-19 Vaccines.
    Martín Oncina J
    Crit Rev Immunol; 2020; 40(6):465-473. PubMed ID: 33900691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus variants are spreading in India - what scientists know so far.
    Vaidyanathan G
    Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409
    [No Abstract]   [Full Text] [Related]  

  • 13. Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA.
    Piano Mortari E; Russo C; Vinci MR; Terreri S; Fernandez Salinas A; Piccioni L; Alteri C; Colagrossi L; Coltella L; Ranno S; Linardos G; Agosta M; Albano C; Agrati C; Castilletti C; Meschi S; Romania P; Roscilli G; Pavoni E; Camisa V; Santoro A; Brugaletta R; Magnavita N; Ruggiero A; Cotugno N; Amodio D; Ciofi Degli Atti ML; Giorgio D; Russo N; Salvatori G; Corsetti T; Locatelli F; Perno CF; Zaffina S; Carsetti R
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies.
    Xie X; Han JB; Ma G; Feng XL; Li X; Zou QC; Deng ZH; Zeng J
    Zool Res; 2021 Nov; 42(6):789-791. PubMed ID: 34704423
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Killer' immune cells still recognize Omicron variant.
    Ledford H
    Nature; 2022 Jan; 601(7893):307. PubMed ID: 35017690
    [No Abstract]   [Full Text] [Related]  

  • 16. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines: modes of immune activation and future challenges.
    Teijaro JR; Farber DL
    Nat Rev Immunol; 2021 Apr; 21(4):195-197. PubMed ID: 33674759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
    Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA
    J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination.
    Lippi G; Sciacovelli L; Trenti T; Plebani M;
    Clin Chem Lab Med; 2021 Jul; 59(8):1333-1335. PubMed ID: 33578505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.